142 related articles for article (PubMed ID: 35193822)
21. Combination of thymidine phosphorylase gene transfer and deoxyinosine treatment greatly enhances 5-fluorouracil antitumor activity in vitro and in vivo.
Ciccolini J; Cuq P; Evrard A; Giacometti S; Pelegrin A; Aubert C; Cano JP; Iliadis A
Mol Cancer Ther; 2001 Dec; 1(2):133-9. PubMed ID: 12467230
[TBL] [Abstract][Full Text] [Related]
22. Thymidine catabolism promotes NADPH oxidase-derived reactive oxygen species (ROS) signalling in KB and yumoto cells.
Tabata S; Yamamoto M; Goto H; Hirayama A; Ohishi M; Kuramoto T; Mitsuhashi A; Ikeda R; Haraguchi M; Kawahara K; Shinsato Y; Minami K; Saijo A; Toyoda Y; Hanibuchi M; Nishioka Y; Sone S; Esumi H; Tomita M; Soga T; Furukawa T; Akiyama SI
Sci Rep; 2018 Apr; 8(1):6760. PubMed ID: 29713062
[TBL] [Abstract][Full Text] [Related]
23. Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.
Stevenson DP; Collins WP; Farzaneh F; Hata K; Miyazaki K
Am J Pathol; 1998 Nov; 153(5):1573-8. PubMed ID: 9811349
[TBL] [Abstract][Full Text] [Related]
24. Thymidine phosphorylase (platelet-derived endothelial cell growth factor) as a target for capecitabine: from biology to the bedside.
Ranieri G; Roccaro AM; Vacca A; Ribatti D
Recent Pat Anticancer Drug Discov; 2006 Jun; 1(2):171-83. PubMed ID: 18221035
[TBL] [Abstract][Full Text] [Related]
25. Effects of thymidine phosphorylase on tumor aggressiveness and 5-fluorouracil sensitivity in cholangiocarcinoma.
Thanasai J; Limpaiboon T; Jearanaikoon P; Sripa B; Pairojkul C; Tantimavanich S; Miwa M
World J Gastroenterol; 2010 Apr; 16(13):1631-8. PubMed ID: 20355241
[TBL] [Abstract][Full Text] [Related]
26. Thymidine phoshorylase as a target for antiangiogenesis treatment.
Peters GJ; Bijnsdorp IV; Fukushima M
Nucleic Acids Symp Ser (Oxf); 2008; (52):629. PubMed ID: 18776537
[TBL] [Abstract][Full Text] [Related]
27. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors.
Brown NS; Jones A; Fujiyama C; Harris AL; Bicknell R
Cancer Res; 2000 Nov; 60(22):6298-302. PubMed ID: 11103787
[TBL] [Abstract][Full Text] [Related]
28. Rapid disappearance of deoxyribose-1-phosphate in platelet derived endothelial cell growth factor/thymidine phosphorylase overexpressing cells.
de Bruin M; Smid K; Laan AC; Noordhuis P; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
Biochem Biophys Res Commun; 2003 Feb; 301(3):675-9. PubMed ID: 12565833
[TBL] [Abstract][Full Text] [Related]
29. Role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in fluoropyrimidine sensitivity.
de Bruin M; van Capel T; Van der Born K; Kruyt FA; Fukushima M; Hoekman K; Pinedo HM; Peters GJ
Br J Cancer; 2003 Mar; 88(6):957-64. PubMed ID: 12644837
[TBL] [Abstract][Full Text] [Related]
30. Importance of thymidine phosphorylase expression in tumor stroma as a prognostic factor in patients with advanced colorectal carcinoma.
Yasuno M; Mori T; Koike M; Takahashi K; Toi M; Takizawa T; Shimizu S; Yamaguchi T; Matsumoto H
Oncol Rep; 2005 Mar; 13(3):405-12. PubMed ID: 15706408
[TBL] [Abstract][Full Text] [Related]
31. [Transfection of thymidine phosphorylase cDNA with lentiviral vector enhances the anticancer effect of 5'-deoxy-5-fluorouridine on colorectal cancer cell lines HT29 and LS174T].
Ye D; Wang Q; Zhang J; Liu Q
Zhonghua Zhong Liu Za Zhi; 2015 Jan; 37(1):18-24. PubMed ID: 25877313
[TBL] [Abstract][Full Text] [Related]
32. [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
Miszczak-Zaborska E; Smolarek M; Bartkowiak J
Postepy Biochem; 2010; 56(1):61-6. PubMed ID: 20499682
[TBL] [Abstract][Full Text] [Related]
33. Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion.
Jones A; Fujiyama C; Turner K; Cranston D; Williams K; Stratford I; Bicknell R; Harris AL
J Urol; 2002 Mar; 167(3):1482-6. PubMed ID: 11832774
[TBL] [Abstract][Full Text] [Related]
34. Novel 6-substituted uracil analogs as inhibitors of the angiogenic actions of thymidine phosphorylase.
Klein RS; Lenzi M; Lim TH; Hotchkiss KA; Wilson P; Schwartz EL
Biochem Pharmacol; 2001 Nov; 62(9):1257-63. PubMed ID: 11705459
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of 5-fluorouracil cytotoxicity by human thymidine-phosphorylase expression in cancer cells: in vitro and in vivo study.
Evrard A; Cuq P; Robert B; Vian L; Pèlegrin A; Cano JP
Int J Cancer; 1999 Jan; 80(3):465-70. PubMed ID: 9935191
[TBL] [Abstract][Full Text] [Related]
36. Induction of thymidine phosphorylase expression by Taxol does not enhance Furtulon sensitivity in a cisplatin-resistant human ovarian carcinoma cell line.
Hata K; Osaki M; Kanasaki H; Nakayama K; Fujiwaki R; Ito H; Miyazaki K
Anticancer Res; 2003; 23(2B):1525-31. PubMed ID: 12820419
[TBL] [Abstract][Full Text] [Related]
37. Mycoplasma pneumoniae thymidine phosphorylase.
Wang L; Schmidl SR; Stülke J
Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):296-304. PubMed ID: 24940683
[TBL] [Abstract][Full Text] [Related]
38. Thymidine phosphorylase: a two-face Janus in anticancer chemotherapy.
Focher F; Spadari S
Curr Cancer Drug Targets; 2001 Aug; 1(2):141-53. PubMed ID: 12188887
[TBL] [Abstract][Full Text] [Related]
39. Increased migration by stimulation of thymidine phosphorylase in endothelial cells of different origin.
Bijnsdorp IV; Vrijland K; Vroling L; Fukushima M; Peters GJ
Nucleosides Nucleotides Nucleic Acids; 2010 Jun; 29(4-6):482-7. PubMed ID: 20544542
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo.
Emura T; Suzuki N; Fujioka A; Ohshimo H; Fukushima M
Int J Oncol; 2005 Aug; 27(2):449-55. PubMed ID: 16010427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
